Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash Flows From Operating Activities:
Net loss	$ (1,369,830)	$ (2,899,612)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation	2,650
Depreciation	21,311	3,524
Amortization of patents	167,780	167,780
Changes in operating assets and liabilities
Settlement receivable	(33,943)	246,284
Prepaid expenses	98,225	99,747
Accounts payable - trade	(1,857,444)	411,271
Other accrued expenses	570,624	24,536
Accrued interest expense	334,574	206,568
Net Cash Used In Operating Activities	(2,066,053)	(1,739,902)
Cash Flows From Financing Activities:
Proceeds from issuance of convertible notes payable	3,775,000	706,000
Proceeds from issuance of convertible notes payable - related parties	25,000	750,000
Proceeds from exercise of warrants	5,330	422,494
Net Cash Provided By Financing Activities	3,805,330	1,878,494
Effect of Exchange Rate Changes on Cash	(22,363)
Net Increase In Cash and Cash Equivalents	1,716,914	138,592
Cash and Cash Equivalents, Beginning of Period	50,986	105,504
Cash and Cash Equivalents, End of Period	1,767,900	244,096
Supplemental Disclosures of Cash Flow Information:
Interest
Taxes
Non-cash investing and financing activities:
Offset of related party receivable and payable	$ 25,000